Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-000291-25Phase 2Terminated
Phase 2, randomised, double-blind trial of betamethasone in nail psoriasis (2 arms), sponsored by IBSA Group. Primary endpoint: Target Nail Psoriasis Severity Index for right and left target fingernails. Started Apr 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-000291-25.